Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00132951 · ClinicalTrials.gov registry record · Phase 4
KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections
A Phase 4 study, sponsored by Sanofi.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2,051
- Enrollment target
NCT00132951 is a Phase 4 study that was terminated before completion, run by Sanofi. The registered enrollment target is 2,051 participants.
The verdict
NCT00132951, a Phase 4 study, was terminated before completion, sponsored by Sanofi.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2,051 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if 1 course of antibiotic treatment with telithromycin is superior to azithromycin in the treatment of lower respiratory tract infections (LRTIs), acute exacerbations of chronic bronchitis (AECBs) and community-acquired pneumonia (CAP) in the community setting.
Interventions
- DRUG Azithromycin
- DRUG Telithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,051 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00132951
The ClinicalTrials.gov registry entry for NCT00132951 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 2,051 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Azithromycin is the first listed.
NCT00132951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00132951 about?
NCT00132951 is a clinical study titled "KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections". The purpose of this study is to determine if 1 course of antibiotic treatment with telithromycin is superior to azithromycin in the treatment of lower respiratory tract infections (LRTIs), acute exacerbations of chronic bronchitis (AECBs) and community-acquired pneumonia (CAP) in the community setti...
What is the current status of trial NCT00132951?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2,051 participants. The study started on 2004-10. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00132951?
The interventions under investigation include: Azithromycin (DRUG), Telithromycin (DRUG).
Who is sponsoring clinical trial NCT00132951?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.